Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients

Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients

Background: Amyotrophic lateral sclerosis (ALS) is a progressive disease characterized by chronic degeneration of upper and lower motor neurons and finally death within 3–5 years usually because of respiratory failure. Riluzole and edaravone are presently available treatments. It may be better to tr...

Full description

Bibliographic Details
Main Authors: Swapnil Samadhiya, Vijay Sardana, Bharat Bhushan, Dilip Maheshwari, Ravi Goyal, Pankaj
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
alsfrs
edaravone
mrs
riluzole
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2022;volume=25;issue=4;spage=692;epage=697;aulast=Samadhiya

Internet

http://www.annalsofian.org/article.asp?issn=0972-2327;year=2022;volume=25;issue=4;spage=692;epage=697;aulast=Samadhiya

Similar Items